GGrantIndex
← Search

DCP Support- HPV16L1/RG1 Virus-Like Particle Vaccine

$774,800N01FY2016CANIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

Initiate preclinical analysis of samples from experimental animals immunized with HPV16L1/RG1. This preclinical work includes three mouse vaccination studies, ELISA validation and testing of mouse samples using antigens and materials needed to initiate L2 neutralization assay validation starting with 2 HPV types.

View original record on NIH RePORTER →